NCT06146972View on ClinicalTrials.gov

Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis

PHASE4RecruitingINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

March 24, 2024

Study Completion Date

May 31, 2024

Conditions

Rheumatoid ArthritisTherapy

Interventions

DRUG

Iguratimod

Iguratimod 25mg bid + tofacitinib 5mg bid

Trial Locations (1)

250000

RECRUITING

Yanfeng Hou, Jinan

All Listed Sponsors

lead

Yanfeng Hou

OTHER